Kazuyuki Itoh and Kiyoko Yoshioka - Free people check

(1 - 10 from 13

)

Clinical trial of continuous intrathecal or intracavitary infusion ...

cancerres.aacrjournals.org

by H Nakagawa · — Hidemitsu Nakagawa, Masakazu Tamura, Yuji Fukushima, Shizuka Majima, Kiyoko Yoshioka and Kazuyuki Itoh. Hidemitsu Nakagawa. › abstract

CiteSeerX — ARTICLE Overexpression of ROCK in Human Breast Cancer...

citeseerx.ist.psu.edu

@MISC{Nishimura_articleoverexpression, author = {Yukio Nishimura and Kazuyuki Itoh and Kiyoko Yoshioka and Kazuo Tokuda and Masaru Himeno}, title = {ARTICLE ...

CiteSeerX — Molecular Cancer BioMed Central

citeseerx.ist.psu.edu

by Yukio Nishimura , Kiyoko Yoshioka , Biborka Bereczky , Kazuyuki Itoh ... {Yukio Nishimura and Kiyoko Yoshioka and Biborka Bereczky and Kazuyuki Itoh},

Evidence for efficient phosphorylation of EGFR and rapid endocytosis...

molecular-cancer.biomedcentral.com

... pathway in a gefitinib-sensitive non-small cell lung cancer cell line. Yukio Nishimura*, Kiyoko Yoshioka, Biborka Bereczky and Kazuyuki Itoh.

Publications Authored by Kiyoko Yoshioka | PubFacts.com

www.pubfacts.com

Kazuyuki Itoh, Kiyoko Yoshioka, Kazuo Tokuda, Masaru Himeno; Pathol Oncol Res ;9(2): Epub Jul 14. Graduate School …

A role of LIM kinase 1/cofilin pathway in regulating endocytic...

link.springer.com

Yukio Nishimura, Kiyoko Yoshioka, Ora Bernard, Biborka Bereczky, and Kazuyuki Itoh. (2006). A role of LIM kinase 1/cofilin pathway in regulating endocytic ...

Oalib search

www.oalib.com

Yukio Nishimura, Kiyoko Yoshioka, Biborka Bereczky, Kazuyuki Itoh Molecular Cancer , 2008, DOI: Abstract: The ...

All web results to the name "Kazuyuki Itoh"

Downregulation of SS18-SSX1 expression in synovial ...

www.spandidos-publications.com

by S Takenaka · · Cited by 29 — Satoshi Takenaka; Norifumi Naka; Nobuhito Araki; Nobuyuki Hashimoto; Takafumi Ueda; Kiyoko Yoshioka; Hideki Yoshikawa; Kazuyuki Itoh. › ijo

Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line-4. Yukio Nishimura, Kiyoko Yoshioka, Biborka Bereczky & Kazuyuki Itoh. Figure published via Figshare. (red) as described in ...